Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies
Michinori Ogura, Kunihiro Tsukasaki, Hirokazu Nagai, Toshiki Uchida, Takashi Oyama, Tatsuya Suzuki, Jun Taguchi, Dai Maruyama, Tomomitsu Hotta, Kensei TobinaiVolume:
103
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1349-7006.2012.02287.x
File:
PDF, 250 KB
english, 2012